Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:SBRA 4 January 2026 - 6 January 2026

Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer

Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer

Sabra Health Care REIT shares fell 0.4% to $19.08 premarket after naming Darrin Smith chief investment officer, effective Jan. 1. Smith’s base salary is set at $470,000, and CFO Michael Costa will add the treasurer role. Smith replaces Talya Nevo-Hacohen, who is retiring. Investors await the next quarterly results for updates on deal activity and funding costs.
6 January 2026
·
MPW stock ends higher to start 2026 as investors watch rates and Medical Properties Trust’s dividend

MPW stock ends higher to start 2026 as investors watch rates and Medical Properties Trust’s dividend

Medical Properties Trust shares rose 1.6% to $5.08 Friday, with 6.2 million shares traded. The company’s next $0.09 dividend is due January 8. U.S. stocks opened 2026 higher as Treasury yields climbed, pressuring dividend stocks. Investors await next week’s jobs and inflation data that could affect rate-sensitive REITs.
4 January 2026
·······

Stock Market Today

  • Smiths Group Shares Fall 6% Despite Strategic Sales and Capital Returns
    March 20, 2026, 7:37 AM EDT. Shares of Smiths Group (LSE:SMIN) dropped 5.9% to 2,222p following mixed half-year results and slightly lowered full-year guidance. The company saw organic revenue growth of 4% and a 7.2% rise in headline operating profit to £248 million, with margins improving 50 basis points to 17.2%. However, statutory profits fell sharply due to one-off charges, causing a 17.4% drop in earnings per share. CEO Roland Carter highlighted the sale of Smiths Detection and Smiths Interconnect as transformational, alongside a £1.5 billion planned shareholder return through 2027. Analysts noted investor disappointment over modest revenue growth and trimmed guidance, despite a 5.4% dividend increase. Long-term outlook remains positive with disposals, acquisitions, and capital returns aiming for mid-term 5-7% organic growth and 21-23% margins, seen as a potential buying opportunity by some market watchers.
Go toTop